Expanding Genomic Testing And AI Will Build Lasting Healthcare Value
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
15 Jun 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$69.50
3.0% overvalued intrinsic discount14 Aug
US$71.59
1Y
51.7%7D
21.9%